The necessity of antiembolic protection systems during transcatheter aortic valve implantation is emphasized due to observed embolism events.
This case report highlights the potential utility of antiembolic protection systems during TAVI by demonstrating objective embolism captured by the device.
Absolute Event Rate: 0% vs 0%
The authors present TAVI in an 82-year-old patient. The feature was objective embolism in antiembolic protection device. The necessity of antiembolic protection systems during transcatheter aortic valve implantation is discussed. The paper suggests possible solutions, and expresses the authors’ opinion.
Kavteladze et al. (Thu,) reported a other. The necessity of antiembolic protection systems during transcatheter aortic valve implantation is emphasized due to observed embolism events.